Übersichtsarbeit
PDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact
Journal of Drugs in Dermatology · 2025
DOI: 10.36849/jdd.9089 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Naiem T Issa und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Phosphodiesterase 4 Inhibitors, Skin Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Phosphodiesterase 4 InhibitorsSkin DiseasesHumansAminopyridinesCyclic Nucleotide Phosphodiesterases, Type 4BenzamidesCyclopropanesPsoriasisTreatment OutcomeThalidomide
Substanzen
Phosphodiesterase 4 InhibitorsRoflumilastAminopyridinesCyclic Nucleotide Phosphodiesterases, Type 4BenzamidesCyclopropanesapremilastThalidomide
Zitieren
APA
Issa, N. T., Obagi, S., Damiani, G., Wang, J., & Bunick, C. G. (2025). PDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.9089
Vancouver
Issa NT, Obagi S, Damiani G, Wang J, Bunick CG. PDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.9089
BibTeX
@article{Issa2025,
author = {Issa, Naiem T and Obagi, Sabine and Damiani, Giovanni and Wang, Jimin and Bunick, Christopher G},
title = {PDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact},
journal = {Journal of Drugs in Dermatology},
year = {2025},
doi = {10.36849/jdd.9089}
}
EUVIMED